Inventor · disambiguated record
Michael Skynner
Also filed as: SKYNNER MICHAEL
10 granted patents·15 pending applications·112 citations·filing 2003–2025
88Inventor score
Top patents by PatentIndex Score
25 records- 0197US11396530B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2020·Granted Jul 26, 2022·16 cites·22 claims
- 0297US11241473B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2020·Granted Feb 8, 2022·16 cites·27 claims
- 0396US10919937B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2019·Granted Feb 16, 2021·29 cites·25 claims
- 0495US10857196B2Bicyclic peptide ligands and uses thereofBICYCLETX LTD·Filed 2018·Granted Dec 8, 2020·20 cites·20 claims
- 0593US11946041B2Modification of polypeptidesBICYCLERD LTD·Filed 2018·Granted Apr 2, 2024·14 cites·17 claims
- 0693US11613560B2Bicyclic peptide ligands specific for OX40BICYCLETX LTD·Filed 2020·Granted Mar 28, 2023·15 cites·26 claims
- 0788US12150998B2Bicyclic peptide ligands specific for P-selectinBICYCLETX LTD·Filed 2022·Granted Nov 26, 2024·1 cites·23 claims
- 0880US11866518B2Bicyclic peptide ligands specific for TSLPBICYCLETX LTD·Filed 2021·Granted Jan 9, 2024·1 cites·19 claims
- 0976US2024391959A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 1073US2025064950A1Bicyclic peptide ligands specific for p-selectinBICYCLETX LTD·Filed 2024·Application pending·0 cites
- 1171US2025340595A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)BICYCLETX LTD·Filed 2025·Application pending·0 cites
- 1267US2025276073A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)BICYCLETX LTD·Filed 2023·Application pending·0 cites
- 1366US11970555B2Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)BICYCLETX LTD·Filed 2021·Granted Apr 30, 2024·0 cites·20 claims
- 1459US2024382605A1Conjugated oligonucleotides and uses thereofIONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1556US2024018508A1Phage cyclisation assayBICYCLERD LTD·Filed 2020·Application pending·0 cites
- 1655US2024108737A1Anti-infective bicyclic peptide ligandsBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 1754US2024083945A1Anti-infective bicyclic peptide ligandsBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 1852US2022281918A1Pbp binding bicyclic peptide ligandsBICYCLETX LTD·Filed 2020·Application pending·0 cites
- 1951US2023106511A1Pbp3 binding bicyclic peptide ligandsBICYCLETX LTD·Filed 2021·Application pending·0 cites
- 2050US2006240420A1Nucleic acid amplification methodDIXON ALASTAIR·Filed 2003·Application pending·0 cites
- 2149US2023086865A1Anti-infective bicyclic peptide conjugatesBICYCLETX LTD·Filed 2021·Application pending·0 cites
- 2248US2025325672A1Anti-infective bicyclic peptide ligandsBICYCLE TX LTD·Filed 2022·Application pending·0 cites
- 2348US2024083944A1Anti-infective bicyclic peptide ligandsBICYCLE TX LTD·Filed 2022·Application pending·0 cites
- 2443US2023183291A1Anti-infective bicyclic peptide ligandsBICYCLE TX LTD·Filed 2021·Application pending·0 cites
- 2542US11904020B2Bicyclic peptide ligands specific for TREM2BICYCLE TX LTD·Filed 2022·Granted Feb 20, 2024·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Michael Skynner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →